Heat Biologics (HTBX) Plans Public Offering of Common Stock and Warrants
StreetInsider.com
(NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies with the goal of activating a patient’s immune system against cancer through T-cell activation, today announced that it intends to offer for sale its common stock and warrants to …
